Respiratory Disease Vaccine Global Market Report 2024

Respiratory Disease Vaccine Global Market Report 2024 – By Type (Viral Vaccine, Bacterial Vaccine, Combination Vaccine), By Infection (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Other Infections), By Age (Infant, Adolescent, Adult), By End-User (Clinic, Hospital, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 175 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Respiratory Disease Vaccine Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Respiratory Disease Vaccine Market Definition And Segments

Respiratory diseases refer to a wide range of conditions that affect the airways and lungs, leading to respiratory symptoms and impaired breathing. Respiratory disease vaccine refers to a type of vaccine that is an immunization designed to protect individuals from respiratory infections caused by viruses or bacteria that primarily affect the respiratory system, which includes the lungs and airways. These vaccines work by stimulating the immune system to produce antibodies that can recognize and fight the specific pathogen that causes the disease.

The main types of respiratory disease vaccines are viral vaccines, bacterial vaccines and combination vaccines. A viral vaccine is a preparation containing weakened or inactivated viruses that stimulate immune responses and are used to prevent respiratory diseases by training the immune system to recognize and defend against specific viruses, reducing infection spread and severity. They are used in treating infections such as COVID-19, influenza, respiratory syncytial virus (RSV), pneumonia and others in infants, adolescents and adult-aged individuals in clinics, hospitals and others.

The respiratory disease vaccine market covered in this report is segmented –

1) By Type: Viral Vaccine, Bacterial Vaccine, Combination Vaccine

2) By Infection: COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Other Infections

3) By Age: Infant, Adolescent, Adult

4) By End-User: Clinic, Hospital, Other End-Users

The respiratory disease vaccine market size has grown steadily in recent years. It will grow from $68.4 billion in 2023 to $69.99 billion in 2024 at a compound annual growth rate (CAGR) of 2.3%. The growth in the historic period can be attributed to rising prevalence of respiratory diseases, increased public vaccination awareness, public health initiatives, growing demand for effective and more tolerable vaccines.

The respiratory disease vaccine market size is expected to see steady growth in the next few years. It will grow to $76.18 billion in 2028 at a compound annual growth rate (CAGR) of 2.1%. The growth in the forecast period can be attributed to aging population, rising healthcare spending, investments in vaccine, pandemic preparedness. Major trends in the forecast period include innovative vaccines, collaborative research, advancement in vaccine development, drug approval.

The Rising Incidence Of Tuberculosis Drives Growth In The Respiratory Disease Vaccine Market

The increasing incidence of tuberculosis is expected to propel the growth of the respiratory disease vaccine market going forward. Tuberculosis (TB) is a type of respiratory disease caused by the bacterium Mycobacterium tuberculosis, which primarily affects the lungs and potentially impacts other organs and systems in the body, leading to various complications. The increasing incidence of tuberculosis can catalyze efforts to develop and distribute respiratory disease vaccines to reduce the spread of tuberculosis. For instance, in October 2022, according to the Global Tuberculosis Report published by the World Health Organization, a Switzerland-based global health agency, the global incidence of tuberculosis (TB) was estimated at 10.6 million cases, with a rate of 134 cases per 100,000 population in 2021, an increase of 4.5% from 10.1 million in 2020. Therefore, the increasing incidence of tuberculosis will drive the respiratory disease vaccine market.

Rising Incidence Of Smoking Boost The Respiratory Disease Vaccine Market

The rising incidence of smoking is expected to propel the growth of the respiratory disease vaccine market going forward. Smoking refers to the act of inhaling and exhaling the smoke produced by burning tobacco or tobacco-containing products that can cause various health risks, including tracheitis, heart disease, stroke, and cancer. Respiratory disease vaccines can provide a degree of protection against specific infections for individuals who smoke. For instance, in July 2022, according to Statistics Canada, a Canada-based government agency, cigarette production increased by 5.8% compared to June 2021. Also, the total number of cigarettes sold rose 1.3% from May 2022, reaching 1.4 billion in June 2022. Therefore, the rising incidence of smoking is driving the growth of the respiratory disease vaccine market.

Major players in the respiratory disease vaccine market are Pfizer Inc., Johnson & Johnson Ltd., Merck & Co. Inc., Sanofi SA, AstraZeneca PLC, GlaxoSmithKline PLC, Sinovac Biotech Co. Ltd., Moderna Inc., BioNTech SE, CSL Limited, Daiichi Sankyo Company Limited, Mitsubishi Tanabe Pharma Corporation, Novavax Inc., Emergent BioSolutions Inc., Seqirus, Bio Farma, Dynavax Technologies Corporation, Hualan Biological Bacterin Co. Ltd., Serum Institute of India Pvt. Ltd., Bavarian Nordic A/S, Valneva SE, Biological E. Limited, CanSino Biologics Inc., Bharat Biotech International Limited, Medicago Inc., CureVac N.V., Incepta Vaccine Ltd., Inovio Pharmaceuticals Inc., Ology Bioservices, VBI Vaccines Inc.

Challenge Of Developing Effective Vaccines For Respiratory Viruses Is A Significant Restraint For The Market

The challenge of developing effective vaccines for respiratory viruses poses a substantial restraint on the growth of the market due to the constantly evolving nature of these viruses, which necessitates ongoing research and development efforts to keep pace with emerging strains, thereby increasing the complexity and cost of vaccine development while potentially delaying their availability to the public. For instance, in March 2023, as per the publication of the National Library of Medicine, a US-based medical library, the COVID-19 pandemic has highlighted the challenge of developing effective respiratory vaccines, particularly against emerging viruses like SARS-associated COVID-19 and avian influenza, due to their high mutation rate and antigenic variability. Therefore, the challenge of developing effective vaccines for respiratory viruses is hindering the growth of the respiratory disease vaccine market.

Major Players Strive For An Improved Solution Enhancing Efficacy And Prevention

Major companies operating in the respiratory disease vaccine market are concentrating on creating innovative products to enhance their efficacy and provide improved solutions for preventing and treating respiratory disease infections. For instance, in May 2023, Pfizer Inc., a US-based pharmaceutical company, received Food and Drug Administration (FDA) approval for ABRYSVO (Respiratory Syncytial Virus Vaccine), the bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccine, for the prevention of lower respiratory tract disease caused by respiratory syncytial virus in individuals 60 years of age and older. ABRYSVO is an unadjuvanted vaccine made up of a pair of preF proteins tailored to maximize immunity to RSV A and B varieties and it has been clinically proven to be safe and productive.

Gsk Acquires Affinivax Inc. To Advance Respiratory Disease Vaccines And Next-Generation Pneumococcal Vaccine Candidate

In August 2022, GSK PLC, a UK-based biopharma company, acquired Affinivax Inc. for an undisclosed amount. Through this acquisition, GSK Plc. will strengthen its commitment to innovate drugs and vaccines, including developing a next-generation 24-valent pneumococcal vaccine candidate (AFX3772). Affinivax Inc. is a US-based clinical-stage biotechnology company focused on developing vaccines and immunotherapies for various diseases, including respiratory diseases.

Asia-Pacific was the largest region in the respiratory disease vaccine market in 2023. North America is expected to be the fastest-growing region in the forecast period. The regions covered in respiratory diseases vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the respiratory diseases vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The respiratory diseases vaccine market consists of sales of the rotavirus vaccine, bordetella vaccine and varicella (chickenpox) vaccine. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The respiratory diseases vaccine market research report is one of a series of new reports from The Business Research Company that provides respiratory diseases vaccine market statistics, including respiratory diseases vaccine industry global market size, regional shares, competitors with a respiratory diseases vaccine market share, detailed respiratory diseases vaccine market segments, market trends and opportunities and any further data you may need to thrive in the respiratory diseases vaccine industry. This respiratory diseases vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Respiratory Disease Vaccine Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $69.99 billion
Revenue Forecast In 2033 $76.18 billion
Growth Rate CAGR of 2.1% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Viral Vaccine, Bacterial Vaccine, Combination Vaccine
2) By Infection: COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Other Infections
3) By Age: Infant, Adolescent, Adult
4) By End-User: Clinic, Hospital, Other End-Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Pfizer Inc.; Johnson & Johnson Ltd.; Merck & Co. Inc.; Sanofi SA; AstraZeneca PLC; GlaxoSmithKline PLC; Sinovac Biotech Co. Ltd.; Moderna Inc.; BioNTech SE; CSL Limited; Daiichi Sankyo Company Limited; Mitsubishi Tanabe Pharma Corporation; Novavax Inc.; Emergent BioSolutions Inc.; Seqirus; Bio Farma; Dynavax Technologies Corporation; Hualan Biological Bacterin Co. Ltd.; Serum Institute of India Pvt. Ltd.; Bavarian Nordic A/S; Valneva SE; Biological E. Limited; CanSino Biologics Inc.; Bharat Biotech International Limited; Medicago Inc; CureVac N.V.; Incepta Vaccine Ltd; Inovio Pharmaceuticals Inc.; Ology Bioservices; VBI Vaccines Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Respiratory Disease Vaccine Market Characteristics

    3. Respiratory Disease Vaccine Market Trends And Strategies

    4. Respiratory Disease Vaccine Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Respiratory Disease Vaccine Market Size and Growth

    5.1. Global Respiratory Disease Vaccine Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Respiratory Disease Vaccine Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Respiratory Disease Vaccine Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Respiratory Disease Vaccine Market Segmentation

    6.1. Global Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Viral Vaccine

    Bacterial Vaccine

    Combination Vaccine

    6.2. Global Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    COVID-19

    Influenza

    Respiratory Syncytial Virus (RSV)

    Pneumonia

    Other Infections

    6.3. Global Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Infant

    Adolescent

    Adult

    6.4. Global Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Clinic

    Hospital

    Other End-Users

    7. Respiratory Disease Vaccine Market Regional And Country Analysis

    7.1. Global Respiratory Disease Vaccine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Respiratory Disease Vaccine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Respiratory Disease Vaccine Market  

    8.1. Asia-Pacific Respiratory Disease Vaccine Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Respiratory Disease Vaccine Market  

    9.1. China Respiratory Disease Vaccine Market Overview  

    9.2. China Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Respiratory Disease Vaccine Market  

    10.1. India Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Respiratory Disease Vaccine Market  

    11.1. Japan Respiratory Disease Vaccine Market Overview  

    11.2. Japan Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Respiratory Disease Vaccine Market  

    12.1. Australia Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Respiratory Disease Vaccine Market  

    13.1. Indonesia Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Respiratory Disease Vaccine Market  

    14.1. South Korea Respiratory Disease Vaccine Market Overview  

    14.2. South Korea Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Respiratory Disease Vaccine Market  

    15.1. Western Europe Respiratory Disease Vaccine Market Overview

    15.2. Western Europe Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Respiratory Disease Vaccine Market  

    16.1. UK Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Respiratory Disease Vaccine Market  

    17.1. Germany Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Respiratory Disease Vaccine Market  

    18.5. France Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Respiratory Disease Vaccine Market  

    19.9. Italy Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Respiratory Disease Vaccine Market  

    20.13. Spain Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Respiratory Disease Vaccine Market  

    21.1. Eastern Europe Respiratory Disease Vaccine Market Overview

    21.2. Eastern Europe Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Respiratory Disease Vaccine Market  

    22.1. Russia Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Respiratory Disease Vaccine Market  

    23.1. North America Respiratory Disease Vaccine Market Overview

    23.2. North America Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Respiratory Disease Vaccine Market  

    24.1. USA Respiratory Disease Vaccine Market Overview

    24.2. USA Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Respiratory Disease Vaccine Market  

    25.1. Canada Respiratory Disease Vaccine Market Overview

    25.2. Canada Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Respiratory Disease Vaccine Market  

    26.1. South America Respiratory Disease Vaccine Market Overview

    26.2. South America Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Respiratory Disease Vaccine Market  

    27.1. Brazil Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Respiratory Disease Vaccine Market  

    28.1. Middle East Respiratory Disease Vaccine Market Overview

    28.2. Middle East Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Respiratory Disease Vaccine Market  

    29.1. Africa Respiratory Disease Vaccine Market Overview

    29.2. Africa Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Respiratory Disease Vaccine Market Competitive Landscape And Company Profiles

    30.1. Respiratory Disease Vaccine Market Competitive Landscape

    30.2. Respiratory Disease Vaccine Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Johnson & Johnson Ltd.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Merck & Co. Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Sanofi SA

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. AstraZeneca PLC

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Respiratory Disease Vaccine Market Other Major And Innovative Companies

    31.1. GlaxoSmithKline PLC

    31.2. Sinovac Biotech Co. Ltd.

    31.3. Moderna Inc.

    31.4. BioNTech SE

    31.5. CSL Limited

    31.6. Daiichi Sankyo Company Limited

    31.7. Mitsubishi Tanabe Pharma Corporation

    31.8. Novavax Inc.

    31.9. Emergent BioSolutions Inc.

    31.10. Seqirus

    31.11. Bio Farma

    31.12. Dynavax Technologies Corporation

    31.13. Hualan Biological Bacterin Co. Ltd.

    31.14. Serum Institute of India Pvt. Ltd.

    31.15. Bavarian Nordic A/S

    32. Global Respiratory Disease Vaccine Market Competitive Benchmarking

    33. Global Respiratory Disease Vaccine Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Respiratory Disease Vaccine Market

    35. Respiratory Disease Vaccine Market Future Outlook and Potential Analysis

    35.1 Respiratory Disease Vaccine Market In 2028 - Countries Offering Most New Opportunities

    35.2 Respiratory Disease Vaccine Market In 2028 - Segments Offering Most New Opportunities

    35.3 Respiratory Disease Vaccine Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Respiratory Disease Vaccine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Respiratory Disease Vaccine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Pfizer Inc. Financial Performance
  • Table 76: Johnson & Johnson Ltd. Financial Performance
  • Table 77: Merck & Co. Inc. Financial Performance
  • Table 78: Sanofi SA Financial Performance
  • Table 79: AstraZeneca PLC Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Respiratory Disease Vaccine Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Respiratory Disease Vaccine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Respiratory Disease Vaccine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Respiratory Disease Vaccine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Respiratory Disease Vaccine Market, Segmentation By Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Respiratory Disease Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Pfizer Inc. Financial Performance
  • Figure 76: Johnson & Johnson Ltd. Financial Performance
  • Figure 77: Merck & Co. Inc. Financial Performance
  • Figure 78: Sanofi SA Financial Performance
  • Figure 79: AstraZeneca PLC Financial Performance
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Respiratory Devices And Equipment (Therapeutic And Diagnostic) Global Market Report 2024 – By Type (Diagnostic devices, Therapeutic devices, Monitoring devices), By Therapeutic Devices (Humidifiers, Nebulizers, Oxygen concentrators, Positive Airway Pressure (PAP) Devices, Ventilators, Other Therapeutic Devices), By Diagnostic Devices (Spirometer, Polysomnographs, Peak Flow Meters), By Monitoring Devices (Pulse oximeters, Capnographs, Gas analyzers), By Application (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Obstructive Sleep Apnea (OSA), Respiratory Distress Syndrome (RDS), Cystic Fibrosis, Pneumonia), By End User (Hospitals, Clinics, Homecare settings, Ambulatory service centers,) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Respiratory Disposables Global Market Report 2024 – By Type (Masks, Tubes, Inhalers, Other Types), By Disease Indications (Asthma, Chronic Obstructive Pulmonary Disorder, Tuberculosis, Lung Cancer, Other Chronic Respiratory Diseases), By Application (Adult, Pediatric & Neonatal), By End User (Hospitals, Clinics, Ambulatory Care Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Respiratory Devices And Equipment (Diagnostic) Global Market Report 2024 – By Product (Instruments And Devices, Assays And Reagents), By Test Type (Traditional Diagnostic Tests, Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests), By Disease Type (Chronic Obstructive Pulmonary Disease, Lung Cancer, Asthma, Tuberculosis, Other Diseases), By End User (Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Respiratory Devices And Equipment (Therapeutic) Global Market Report 2024 – By Product (Nebulizers, Humidifiers, Oxygen Concentrators, Positive Airway Pressure Devices, Ventilators, Capnographs, Gas Analyzers), By Technology (HEPA Filter, Electrostatic Filtration, Microsphere Separation, Hollow Fiber Filtration, Other Technologies), By End-User (Homecare settings, Hospitals) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Respiratory Monitoring Devices Global Market Report 2024 – By Type (Capnographs, Gas Analyzers, Pulse Oximeters, Peak Flow Meters, Spirometers, Polysomnographs, Others Types), By Application (Chronic Obstructive Pulmonary Disease (COPD), Infectious Diseases, Asthma, Other Applications), By End-User (Laboratories, Hospitals, Home Use) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Anesthesia And Respiratory Devices Global Market Report 2024 – By Type (Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables), By Gender (Male, Female), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Respiratory Disease Testing Global Market Report 2024 – By Test Type (Imaging Tests, Mechanical Tests, In-Vitro Diagnostic Tests), By Products (Lung Volume, Imaging, Spirometry, Peak Flow, Blood Gas, Other Products), By Application (Chronic Obstructive Pulmonary Disease, Lung Cancer, Asthma, Tuberculosis Female, Other Application), By End-User (Hospitals, Physician clinics, Clinical laboratories, Other End-User) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Respiratory Protection Equipment Global Market Report 2024 – By Product (Air Purifying Respirators (APR), Supplied Air Respirators), By Filter Type (Particle, Gas And Vapor, Compiled Filters), By Distribution Channel (Direct And institutional Sales, Retail Sales), By End-User (Oil And Gas, Fire Services, Petrochemical And Chemical, Industrial, Pharmaceuticals, Construction, Healthcare, Mining, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the respiratory disease vaccine market?

Respiratory diseases refer to a wide range of conditions that affect the airways and lungs, leading to respiratory symptoms and impaired breathing. Respiratory disease vaccine refers to a type of vaccine that is an immunization designed to protect individuals from respiratory infections caused by viruses or bacteria that primarily affect the respiratory system, which includes the lungs and airways. These vaccines work by stimulating the immune system to produce antibodies that can recognize and fight the specific pathogen that causes the disease. request a sample here

How will the respiratory disease vaccine market drivers and restraints affect the respiratory disease vaccine market dynamics? What forces will shape the respiratory disease vaccine industry going forward?

The respiratory disease vaccine market major growth driver - The Rising Incidence Of Tuberculosis Drives Growth In The Respiratory Disease Vaccine Market. request a sample here

What is the forecast market size or the forecast market value of the respiratory disease vaccine market?

The respiratory disease vaccine market size has grown steadily in recent years. It will grow from $68.4 billion in 2023 to $69.99 billion in 2024 at a compound annual growth rate (CAGR) of 2.3%. The growth in the historic period can be attributed to rising prevalence of respiratory diseases, increased public vaccination awareness, public health initiatives, growing demand for effective and more tolerable vaccines. The respiratory disease vaccine market size is expected to see steady growth in the next few years. It will grow to $76.18 billion in 2028 at a compound annual growth rate (CAGR) of 2.1%. The growth in the forecast period can be attributed to aging population, rising healthcare spending, investments in vaccine, pandemic preparedness. Major trends in the forecast period include innovative vaccines, collaborative research, advancement in vaccine development, drug approval. request a sample here

How is the respiratory disease vaccine market segmented?

The respiratory disease vaccine market is segmented
1) By Type: Viral Vaccine, Bacterial Vaccine, Combination Vaccine
2) By Infection: COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Other Infections
3) By Age: Infant, Adolescent, Adult
4) By End-User: Clinic, Hospital, Other End-UsersFor further insights on the respiratory disease vaccine market request a sample here

Which region has the largest share of the respiratory disease vaccine market? What are the other regions covered in the report?

Asia-Pacific was the largest region in the respiratory disease vaccine market in 2023. North America is expected to be the fastest-growing region in the forecast period. The regions covered in respiratory diseases vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. request a sample here.

Who are the major players in the respiratory disease vaccine market?

Major players in the respiratory disease vaccine market are Pfizer Inc., Johnson & Johnson Ltd., Merck & Co. Inc., Sanofi SA, AstraZeneca PLC, GlaxoSmithKline PLC, Sinovac Biotech Co. Ltd., Moderna Inc., BioNTech SE, CSL Limited, Daiichi Sankyo Company Limited, Mitsubishi Tanabe Pharma Corporation, Novavax Inc., Emergent BioSolutions Inc., Seqirus, Bio Farma, Dynavax Technologies Corporation, Hualan Biological Bacterin Co. Ltd., Serum Institute of India Pvt. Ltd., Bavarian Nordic A/S, Valneva SE, Biological E. Limited, CanSino Biologics Inc., Bharat Biotech International Limited, Medicago Inc., CureVac N.V., Incepta Vaccine Ltd., Inovio Pharmaceuticals Inc., Ology Bioservices, VBI Vaccines Inc. request a sample here.

What are the key trends in the respiratory disease vaccine market?

Major trend in the respiratory disease vaccine market - Major Players Strive For An Improved Solution Enhancing Efficacy And Prevention. request a sample here.

What are the major opportunities in the respiratory disease vaccine market? What are the strategies for the respiratory disease vaccine market?

For detailed insights on the major opportunities and strategies in the respiratory disease vaccine market, request a sample here.

How does the respiratory disease vaccine market relate to the overall economy and other similar markets?

For detailed insights on respiratory disease vaccine market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the respiratory disease vaccine industry?

For detailed insights on the mergers and acquisitions in the respiratory disease vaccine industry, request a sample here.

What are the key dynamics influencing the respiratory disease vaccine market growth? SWOT analysis of the respiratory disease vaccine market.

For detailed insights on the key dynamics influencing the respiratory disease vaccine market growth and SWOT analysis of the respiratory disease vaccine industry, request a sample here.